PMTI » Topics » Signatures

This excerpt taken from the PMTI 8-K filed Dec 4, 2009.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


This excerpt taken from the PMTI 8-K filed Oct 29, 2009.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


This excerpt taken from the PMTI 8-K filed Oct 16, 2009.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


This excerpt taken from the PMTI 8-K filed Jul 30, 2009.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


This excerpt taken from the PMTI 8-K filed Jun 5, 2009.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


This excerpt taken from the PMTI 10-Q filed May 7, 2009.

Signatures

  Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Palomar Medical Technologies, Inc.
(Registrant)


Date: May 7, 2009  By:/s/ Joseph P. Caruso       
      Joseph P. Caruso
      President, Chief Executive Officer and Director

Date: May 7, 2009  By:/s/ Paul S. Weiner       
      Paul S. Weiner
      Vice President and Chief Financial Officer





42


This excerpt taken from the PMTI 8-K filed Apr 30, 2009.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


This excerpt taken from the PMTI 10-K filed Mar 5, 2009.

SIGNATURES

        Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Palomar Medical Technologies, Inc.

  By:/s/ Paul S. Weiner       
      Paul S. Weiner
      Chief Financial Officer


        Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed by the following persons on behalf of the registrant in the capacities and on the dates indicated.


Name Capacity Date
     
/s/Louis P. Valente               Chairman of the Board of Directors March 5, 2009
Louis P. Valente
     
/s/Joseph P. Caruso                President, Chief Executive Officer and Director March 5, 2009
Joseph P. Caruso
     
/s/Paul S. Weiner                Chief Financial Officer March 5, 2009
Paul S. Weiner
     
/s/ Nicholas P. Economou         Director March 5, 2009
Nicholas P. Economou
     
/s/ A. Neil Pappalardo                Director March 5, 2009
A. Neil Pappalardo
     
/s/ James G. Martin                Director March 5, 2009
James G. Martin
     
/s/ Jeanne Cohane                Director March 5, 2009
Jeanne Cohane
     

89


This excerpt taken from the PMTI 8-K filed Feb 5, 2009.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


This excerpt taken from the PMTI 8-K filed Jan 8, 2009.

SIGNATURES

      Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


This excerpt taken from the PMTI 8-K filed Jan 8, 2009.

SIGNATURES

      Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


This excerpt taken from the PMTI 10-Q filed Nov 4, 2008.

Signatures

        Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


Palomar Medical Technologies, Inc.
(Registrant)


Date: November 4, 2008  By:/s/ Joseph P. Caruso       
      Joseph P. Caruso
      President, Chief Executive Officer and Director

Date: November 4, 2008  By:/s/ Paul S. Weiner       
      Paul S. Weiner
      Vice President and Chief Financial Officer





41


This excerpt taken from the PMTI 8-K filed Oct 31, 2008.

SIGNATURES

      Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


This excerpt taken from the PMTI 8-K filed Oct 30, 2008.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


This excerpt taken from the PMTI 8-K filed Oct 8, 2008.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


This excerpt taken from the PMTI 10-Q filed Aug 7, 2008.

Signatures

        Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


Palomar Medical Technologies, Inc.
(Registrant)


Date: August 7, 2008  By:/s/ Joseph P. Caruso       
      Joseph P. Caruso
      President, Chief Executive Officer and Director

Date: August 7, 2008  By:/s/ Paul S. Weiner       
      Paul S. Weiner
      Vice President and Chief Financial Officer





43


This excerpt taken from the PMTI 8-K filed Jul 31, 2008.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


This excerpt taken from the PMTI 8-K filed May 1, 2008.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


This excerpt taken from the PMTI 8-K filed Mar 20, 2008.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


This excerpt taken from the PMTI 10-K filed Mar 6, 2008.

SIGNATURES

        Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Palomar Medical Technologies, Inc.

  By:/s/ Paul S. Weiner       
      Paul S. Weiner
      Chief Financial Officer


        Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed by the following persons on behalf of the registrant in the capacities and on the dates indicated.


Name Capacity Date
     
/s/Louis P. Valente               Chairman of the Board of Directors March 6, 2008
Louis P. Valente
     
/s/Joseph P. Caruso                President, Chief Executive Officer and Director March 6, 2008
Joseph P. Caruso
     
/s/Paul S. Weiner                Chief Financial Officer March 6, 2008
Paul S. Weiner
     
/s/ Nicholas P. Economou         Director March 6, 2008
Nicholas P. Economou
     
/s/ A. Neil Pappalardo                Director March 6, 2008
A. Neil Pappalardo
     
/s/ James G. Martin                Director March 6, 2008
James G. Martin
     
/s/ Jeanne Cohane                Director March 6, 2008
Jeanne Cohane
     

78


This excerpt taken from the PMTI 8-K filed Mar 3, 2008.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


This excerpt taken from the PMTI 8-K filed Feb 11, 2008.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


This excerpt taken from the PMTI 8-K filed Feb 7, 2008.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


This excerpt taken from the PMTI 8-K filed Jan 9, 2008.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


This excerpt taken from the PMTI 8-K filed Dec 21, 2007.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


This excerpt taken from the PMTI 10-Q filed Nov 2, 2007.

Signatures

        Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant certifies that it has caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.


Palomar Medical Technologies, Inc.
(Registrant)


Date: November 2, 2007  By:/s/ Joseph P. Caruso       
      Joseph P. Caruso
      President, Chief Executive Officer and Director

Date: November 2, 2007  By:/s/ Paul S. Weiner       
      Paul S. Weiner
      Vice President and Chief Financial Officer





40


This excerpt taken from the PMTI 8-K filed Oct 25, 2007.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


This excerpt taken from the PMTI 8-K filed Oct 24, 2007.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


This excerpt taken from the PMTI 10-Q filed Aug 3, 2007.

Signatures

        Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant certifies that it has caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

Palomar Medical Technologies, Inc.
(Registrant)


Date: August 3, 2007  By:/s/ Joseph P. Caruso       
      Joseph P. Caruso
      President, Chief Executive Officer and Director

Date: August 3, 2007  By:/s/ Paul S. Weiner       
      Paul S. Weiner
      Vice President and Chief Financial Officer





38


This excerpt taken from the PMTI 8-K filed Jul 26, 2007.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


This excerpt taken from the PMTI 10-Q filed May 8, 2007.

Signatures

        Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant certifies that it has caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.


Palomar Medical Technologies, Inc.
(Registrant)


Date: May 8, 2007  By:/s/ Joseph P. Caruso       
      Joseph P. Caruso
      President, Chief Executive Officer and Director

Date: May 8, 2007  By:/s/ Paul S. Weiner       
      Paul S. Weiner
      Vice President and Chief Financial Officer





36


This excerpt taken from the PMTI 8-K filed Apr 26, 2007.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


This excerpt taken from the PMTI 8-K filed Apr 2, 2007.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


This excerpt taken from the PMTI 10-K filed Mar 8, 2007.

SIGNATURES

        Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on March 7, 2007.

Palomar Medical Technologies, Inc.

  By:/s/ Paul S. Weiner       
      Paul S. Weiner
      Chief Financial Officer

        Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed by the following persons on behalf of the registrant in the capacities and on the dates indicated.


Name Capacity Date
     
/s/Louis P. Valente               Chairman of the Board of Directors March 7, 2007
Louis P. Valente
     
/s/Joseph P. Caruso             President, Chief Executive Officer March 7, 2007
Joseph P. Caruso and Director
     
/s/Paul S. Weiner                  Chief Financial Officer March 7, 2007
Paul S. Weiner
     
/s/Nicholas P. Economou    Director March 7, 2007
Nicholas P. Economou
     
/s/A. Neil Pappalardo          Director March 7, 2007
A. Neil Pappalardo
     
/s/James G. Martin               Director March 7, 2007
James G. Martin
     
/s/Jeanne Cohane                Director March 7, 2007
Jeanne Cohane

68


This excerpt taken from the PMTI 8-K filed Feb 21, 2007.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


This excerpt taken from the PMTI 8-K filed Feb 9, 2007.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


This excerpt taken from the PMTI 8-K filed Feb 8, 2007.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


This excerpt taken from the PMTI 8-K filed Dec 11, 2006.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


This excerpt taken from the PMTI 8-K filed Nov 7, 2006.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


This excerpt taken from the PMTI 10-Q filed Nov 3, 2006.

Signatures

        Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant certifies that it has caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.


Palomar Medical Technologies, Inc.
(Registrant)


Date: November 3, 2006  By:/s/ Joseph P. Caruso       
      Joseph P. Caruso
      President, Chief Executive Officer and Director

Date: November 3, 2006  By:/s/ Paul S. Weiner       
      Paul S. Weiner
      Vice President and Chief Financial Officer

35


This excerpt taken from the PMTI 8-K filed Oct 26, 2006.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


This excerpt taken from the PMTI 10-Q filed Aug 8, 2006.

Signatures

        Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant certifies that it has caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

Palomar Medical Technologies, Inc.
(Registrant)


Date: August 8, 2006  By:/s/ Joseph P. Caruso       
      Joseph P. Caruso
      President, Chief Executive Officer and Director

Date: August 8, 2006  By:/s/ Paul S. Weiner       
      Paul S. Weiner
      Vice President and Chief Financial Officer

34


This excerpt taken from the PMTI 8-K filed Jul 27, 2006.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


This excerpt taken from the PMTI 8-K filed Jun 5, 2006.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.




Date: June 5, 2006

PALOMAR MEDICAL TECHNOLOGIES, INC.

By: /s/ Joseph P. Caruso
——————————————
Joseph P. Caruso
Chief Executive Officer and President









This excerpt taken from the PMTI 10-Q filed May 9, 2006.

Signatures

        Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant certifies that it has caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.


Palomar Medical Technologies, Inc.
(Registrant)


Date: May 9, 2006  By: /s/ Joseph P. Caruso   
      Joseph P. Caruso
      President, Chief Executive Officer and Director


Date: May 9, 2006  By:/s/ Paul S. Weiner       
      Paul S. Weiner
      Vice President and Chief Financial Officer

30


This excerpt taken from the PMTI 8-K filed Apr 27, 2006.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


This excerpt taken from the PMTI 10-K filed Mar 6, 2006.

SIGNATURES

        Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on March 6, 2006.


PALOMAR MEDICAL TECHNOLOGIES, INC.


By: /s/ Paul S. Weiner
——————————————
Paul S. Weiner
Chief Financial Officer

        Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed by the following persons on behalf of the registrant in the capacities and on the dates indicated.


Name Capacity Date
     
/s/ Louis P. Valente      Chairman of the Board of Directors March 6, 2006
Louis P. Valente
     
/s/ Joseph P. Caruso    President, Chief Executive Officer and March 6, 2006
Joseph P. Caruso Director
     
/s/ Paul S. Weiner       Chief Financial Officer March 6, 2006
Paul S. Weiner
     
/s/ Nicholas P. Economou Director March 6, 2006
Nicholas P. Economou
     
/s/ A. Neil Pappalardo Director March 6, 2006
A. Neil Pappalardo
     
/s/ James G. Martin    Director March 6, 2006
James G. Martin
     
/s/ Jeanne Cohane    Director March 6, 2006
Jeanne Cohane

58


This excerpt taken from the PMTI 8-K filed Feb 9, 2006.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


This excerpt taken from the PMTI 8-K filed Oct 27, 2005.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


This excerpt taken from the PMTI 10-Q filed Aug 5, 2005.

Signatures

        Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant certifies that it has caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

Palomar Medical Technologies, Inc.
(Registrant)


Date: August 5, 2005  By: /s/ Joseph P. Caruso   
      Joseph P. Caruso
      President, Chief Executive Officer and Director


Date: August 5, 2005  By:/s/ Paul S. Weiner       
      Paul S. Weiner
      Vice President and Chief Financial Officer


27


This excerpt taken from the PMTI 8-K filed Jul 28, 2005.

SIGNATURES

          Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

PALOMAR MEDICAL TECHNOLOGIES, INC.

 

 

 

 

By:

/s/ JOSEPH P. CARUSO

 

 


 

 

Chief Executive Officer and

 

 

President

Date:  July 28, 2005

 

 



This excerpt taken from the PMTI 10-Q filed May 5, 2005.

Signatures

        Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant certifies that it has caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

Palomar Medical Technologies, Inc.
(Registrant)


Date: May 5, 2005  By: /s/ Joseph P. Caruso   
      Joseph P. Caruso
      President, Chief Executive Officer and Director


Date: May 5, 2005  By:/s/ Paul S. Weiner       
      Paul S. Weiner
      Vice President and Chief Financial Officer


-25-


This excerpt taken from the PMTI 8-K filed Apr 28, 2005.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


This excerpt taken from the PMTI 10-K filed Mar 11, 2005.

SIGNATURES

        Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on March 10, 2005.

PALOMAR MEDICAL TECHNOLOGIES, INC.


By: /s/ Paul S. Weiner
——————————————
Paul S. Weiner
Chief Financial Officer

        Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed by the following persons on behalf of the registrant in the capacities and on the dates indicated.


Name   Capacity   Date  

/s/ Louis P. Valente
——————————————
Louis P. Valente
Chairman of the Board of Directors March 10, 2005


/s/ Joseph P. Caruso
——————————————
Joseph P. Caruso
President, Chief Executive Officer and Director March 10, 2005


/s/ Paul S. Weiner
——————————————
Paul S. Weiner
Chief Financial Officer March 10, 2005


/s/ Nicholas P. Economou
——————————————
Nicholas P. Economou
Director March 10, 2005


/s/ A. Neil Pappalardo
——————————————
A. Neil Pappalardo
Director March 10, 2005


/s/ James G. Martin
——————————————
James G. Martin
Director March 10, 2005


/s/ Jeanne Cohane
——————————————
Jeanne Cohane
Director March 10, 2005

-57-


This excerpt taken from the PMTI 8-K filed Feb 11, 2005.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.




Date: February 11, 2005

PALOMAR MEDICAL TECHNOLOGIES, INC.

By: /s/ Joseph P. Caruso
——————————————
Joseph P. Caruso
Chief Executive Officer and President









This excerpt taken from the PMTI 8-K filed Feb 10, 2005.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki